Your browser doesn't support javascript.
loading
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Flowers, Christopher R; Costa, Luciano J; Pasquini, Marcelo C; Le-Rademacher, Jennifer; Lill, Michael; Shore, Tsiporah B; Vaughan, William; Craig, Michael; Freytes, Cesar O; Shea, Thomas C; Horwitz, Mitchell E; Fay, Joseph W; Mineishi, Shin; Rondelli, Damiano; Mason, James; Braunschweig, Ira; Ai, Weiyun; Yeh, Rosa F; Rodriguez, Tulio E; Flinn, Ian; Comeau, Terrance; Yeager, Andrew M; Pulsipher, Michael A; Bence-Bruckler, Isabelle; Laneuville, Pierre; Bierman, Philip; Chen, Andy I; Kato, Kazunobu; Wang, Yanlin; Xu, Cong; Smith, Angela J; Waller, Edmund K.
Affiliation
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute, Division of BMT, Emory University, Atlanta, Georgia.
  • Costa LJ; Medical University of South Carolina, Charleston, South Carolina.
  • Pasquini MC; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Le-Rademacher J; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Lill M; Cedars-Sinai Medical Center, Los Angeles, California.
  • Shore TB; Weill Cornell Medical Center Hematology/Oncology, The New York Hospital, New York, New York.
  • Vaughan W; Bone Marrow Transplantation Program, University of Alabaman at Birmingham, Birmingham, Alabama.
  • Craig M; West Virginia University, Health Science Center, Morgantown, West Virginia.
  • Freytes CO; South Texas Veterans Health Care System, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Shea TC; Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.
  • Horwitz ME; Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Fay JW; Baylor University Medical Center, Dallas, Texas.
  • Mineishi S; Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan.
  • Rondelli D; Department of Medicine, Section of Hematology-Oncology, University of Illinois at Chicago, Chicago, Illinois.
  • Mason J; Scripps Clinic, La Jolla, California.
  • Braunschweig I; Department of Oncology, Montefiore Medical Center, Bronx, New York.
  • Ai W; Medicine, University of California, San Francisco, San Francisco, California.
  • Yeh RF; Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rodriguez TE; Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois.
  • Flinn I; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Comeau T; New Brunswick Stem Cell Transplant Program, St. John, New Brunswick, Canada.
  • Yeager AM; Blood and Marrow Transplantation Program, The University of Arizona Cancer Center, Tucson, Arizona.
  • Pulsipher MA; Division of Hematology, Oncology, and Blood and Marrow Transplant, Children's Hospital Los Angeles, Keck School of Medicine and University of Southern California, Los Angeles, California.
  • Bence-Bruckler I; The University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Laneuville P; Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Bierman P; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • Chen AI; Center for Hematologic Malignancies, Oregon Health & Science University, Portland, Oregon.
  • Kato K; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
  • Wang Y; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
  • Xu C; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
  • Smith AJ; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Division of BMT, Emory University, Atlanta, Georgia. Electronic address: ewaller@emory.edu.
Biol Blood Marrow Transplant ; 22(7): 1197-1205, 2016 07.
Article in En | MEDLINE | ID: mdl-27040394
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Busulfan / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Cyclophosphamide / Etoposide / Lymphoma Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2016 Type: Article Affiliation country: Georgia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Busulfan / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Cyclophosphamide / Etoposide / Lymphoma Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2016 Type: Article Affiliation country: Georgia